A former scientist at Google's DeepMind who co-developed the AlphaFold2 protein prediction platform, Dr Simon Kohl, has launched his own venture applying artificial intelligence to drug discovery.
This scheme has consistently delivered the best returns in its Multi Asset Allocation category across . This scheme has maintained a relatively low level of volatility within its Multi Asset ...
This scheme has consistently delivered the best returns in its Fund of Funds category across . This scheme has maintained a relatively low level of volatility within its Fund of Funds category over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback